Page 23 - Mesenchymal Stem cells, Exosomes and vitamins in the fight aginst COVID
P. 23

Al-Khawaga and Abdelalim Stem Cell Research & Therapy          (2020) 11:437            Page 4 of 33






























































              Fig. 1 Immunopathogenesis of the SARS-CoV-2. The alveolar epithelium consists of a monolayer of alveolar type I (AT1) cells and alveolar type II (AT2)
              cells. Under normal condition, the AT2 cells secrete surfactant covering all the lining epithelium to facilitate alveolus expansion. AT1 and AT2 are tightly
              connected with tight junctions, which control the transfer of ions and fluid across the epithelium. The endothelial cells of the blood capillaries are
              connected by intercellular junctions and control the influx of inflammatory cells and fluid into the interstitial space. SARS-CoV-2 infects AT2 cells and
              resident alveolar macrophages that express ACE2. This activation induces chemokine secretion that recruits inflammatory and immune cells into the
              infected alveoli. The increased inflammatory cells in the lung lead to secretion of large amounts of pro-inflammatory cytokines “cytokine storm” that lead
              to damages in the lung. The migrated neutrophils and monocytes release toxic mediators, causing endothelial and epithelial injuries. The intercellular
              junctions are disrupted leading to formation of gaps between the alveolar cells as well as between the endothelial cells, resultinginanincreaseinthe
              permeability of the epithelial and endothelial cells. The increase in the permeability facilitates the migration of inflammatory cells and allows the influx of
              RBCs and fluid from the blood capillary. Large volume of fluid (alveolar edema) fills the airspace leading to a difficulty in the breathing. Also, the
              inflammatory reactions may lead to alveolar cell death, fibrin deposition, and hyaline membrane formation


            defining criteria for MSCs is that they adhere to plas-  adipogenic, osteogenic, and chondrogenic lineages
            tic, express the surface markers CD90, CD73, and  [26].
            CD105, are negative for the hematopoietic markers   Bone marrow MSCs (BM-MSCs) are considered the
            CD14, CD34, CD45, CD19, and HLA-DR, and should    most widely used and investigated type of MSCs, which
            express a multilineage differentiation capability into  was first isolated from the bone marrow by Friedenstein
   18   19   20   21   22   23   24   25   26   27   28